Interference with Sin3 Function Induces Epigenetic Reprogramming and Differentiation in Breast Cancer Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2010 Jun 16

PMID 20547842

Citations 38

Authors

Eduardo F Farias

Kevin Petrie

Boris Leibovitch

Janice Murtagh

Manuel Boix Chornet

Tino Schenk

Arthur Zelent

Samuel Waxman

Affiliations

Soon will be listed here.

Abstract

Sin3A/B is a master transcriptional scaffold and corepressor that plays an essential role in the regulation of gene transcription and maintenance of chromatin structure, and its inappropriate recruitment has been associated with aberrant gene silencing in cancer. Sin3A/B are highly related, large, multidomian proteins that interact with a wide variety of transcription factors and corepressor components, and we examined whether disruption of the function of a specific domain could lead to epigenetic reprogramming and derepression of specific subsets of genes. To this end, we selected the Sin3A/B-paired amphipathic alpha-helices (PAH2) domain based on its established role in mediating the effects of a relatively small number of transcription factors containing a PAH2-binding motif known as the Sin3 interaction domain (SID). Here, we show that in both human and mouse breast cancer cells, the targeted disruption of Sin3 function by introduction of a SID decoy that interferes with PAH2 binding to SID-containing partner proteins reverted the silencing of genes involved in cell growth and differentiation. In particular, the SID decoy led to epigenetic reprogramming and reexpression of the important breast cancer-associated silenced genes encoding E-cadherin, estrogen receptor alpha, and retinoic acid receptor beta and impaired tumor growth in vivo. Interestingly, the SID decoy was effective in the triple-negative M.D. Anderson-Metastatic Breast-231 (MDA-MB-231) breast cancer cell line, restoring sensitivity to 17beta-estradiol, tamoxifen, and retinoids. Therefore, the development of small molecules that can block interactions between PAH2 and SID-containing proteins offers a targeted epigenetic approach for treating this type of breast cancer that may also have wider therapeutic implications.

Citing Articles

SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer.

Zhang Z, Tang Y, Wang Y, Xu J, Yang X, Liu M Adv Sci (Weinh). 2024; 11(43):e2402244.

PMID: 39316363 PMC: 11578377. DOI: 10.1002/advs.202402244.

Durable CRISPR-Based Epigenetic Silencing.

Nakamura M, Ivec A, Gao Y, Qi L Biodes Res. 2023; 2021:9815820.

PMID: 37849948 PMC: 10521745. DOI: 10.34133/2021/9815820.

A computational framework for the inference of protein complex remodeling from whole-proteome measurements.

Buljan M, Banaei-Esfahani A, Blattmann P, Meier-Abt F, Shao W, Vitek O Nat Methods. 2023; 20(10):1523-1529.

PMID: 37749212 PMC: 10555833. DOI: 10.1038/s41592-023-02011-w.

Two assembly modes for SIN3 histone deacetylase complexes.

Wang C, Guo Z, Chu C, Lu Y, Zhang X, Zhan X Cell Discov. 2023; 9(1):42.

PMID: 37076472 PMC: 10115800. DOI: 10.1038/s41421-023-00539-x.

Distinct biochemical properties of the class I histone deacetylase complexes.

Lee K, Whedon S, Wang Z, Cole P Curr Opin Chem Biol. 2022; 70:102179.

PMID: 35803024 PMC: 10786639. DOI: 10.1016/j.cbpa.2022.102179.

References

Silverstein R, Ekwall K . Sin3: a flexible regulator of global gene expression and genome stability. Curr Genet. 2004; 47(1):1-17. DOI: 10.1007/s00294-004-0541-5. View

Fraga M, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G . Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005; 37(4):391-400. DOI: 10.1038/ng1531. View

Debnath J, Muthuswamy S, Brugge J . Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003; 30(3):256-68. DOI: 10.1016/s1046-2023(03)00032-x. View

Moshkin Y, Kan T, Goodfellow H, Bezstarosti K, Maeda R, Pilyugin M . Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing. Mol Cell. 2009; 35(6):782-93. DOI: 10.1016/j.molcel.2009.07.020. View

Pruitt K, Zinn R, Ohm J, McGarvey K, Kang S, Watkins D . Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2006; 2(3):e40. PMC: 1420676. DOI: 10.1371/journal.pgen.0020040. View

van Oevelen C, Wang J, Asp P, Yan Q, Kaelin Jr W, Kluger Y . A role for mammalian Sin3 in permanent gene silencing. Mol Cell. 2008; 32(3):359-70. PMC: 3100182. DOI: 10.1016/j.molcel.2008.10.015. View

Frigola J, Song J, Stirzaker C, Hinshelwood R, Peinado M, Clark S . Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet. 2006; 38(5):540-9. DOI: 10.1038/ng1781. View

Petrie K, Zelent A, Waxman S . Differentiation therapy of acute myeloid leukemia: past, present and future. Curr Opin Hematol. 2009; 16(2):84-91. DOI: 10.1097/MOH.0b013e3283257aee. View

Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P . An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell. 1995; 80(5):777-86. DOI: 10.1016/0092-8674(95)90356-9. View

10.

Leong K, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I . Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med. 2007; 204(12):2935-48. PMC: 2118507. DOI: 10.1084/jem.20071082. View

11.

Dworkin A, Huang T, Toland A . Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin Cancer Biol. 2009; 19(3):165-71. PMC: 2734184. DOI: 10.1016/j.semcancer.2009.02.007. View

12.

Zelent A, Petrie K, Boix-Chornet M, Melnick A, Waxman S, Gore S . Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics. Cancer Res. 2008; 68(13):4967-70. PMC: 2864592. DOI: 10.1158/0008-5472.CAN-07-6779. View

13.

Ooi S, Qiu C, Bernstein E, Li K, Jia D, Yang Z . DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature. 2007; 448(7154):714-7. PMC: 2650820. DOI: 10.1038/nature05987. View

14.

Cardarelli F, Serresi M, Bizzarri R, Beltram F . Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells. Traffic. 2008; 9(4):528-39. DOI: 10.1111/j.1600-0854.2007.00696.x. View

15.

Lombaerts M, van Wezel T, Philippo K, Dierssen J, Zimmerman R, Oosting J . E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer. 2006; 94(5):661-71. PMC: 2361216. DOI: 10.1038/sj.bjc.6602996. View

16.

Kuppumbatti Y, Bleiweiss I, Mandeli J, Waxman S, Mira-y-Lopez R . Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst. 2000; 92(6):475-80. DOI: 10.1093/jnci/92.6.475. View

17.

Ayer D, Lawrence Q, Eisenman R . Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell. 1995; 80(5):767-76. DOI: 10.1016/0092-8674(95)90355-0. View

18.

Wong A, Gumbiner B . Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol. 2003; 161(6):1191-203. PMC: 2173007. DOI: 10.1083/jcb.200212033. View

19.

Barrett A, Santangelo S, Tan K, Catchpole S, Roberts K, Spencer-Dene B . Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. Int J Cancer. 2007; 121(2):265-75. DOI: 10.1002/ijc.22673. View

20.

Farias E, Ong D, Ghyselinck N, Nakajo S, Kuppumbatti Y, Mira y Lopez R . Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst. 2005; 97(1):21-9. DOI: 10.1093/jnci/dji004. View